Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS (2014). Diabetic foot ulcers: Part I. Pathophysiology and prevention. J. Am. Acad. Dermatol. 70(1):1-e1.
Crossref

Albert S (2002). Cost-effective management of recalcitrant diabetic foot ulcers. Clin. Podiatr. Med. Surg. 19(4):483-491.
Crossref

Allam AM, Mostafa W, Zayed E, El-Gamaly J (2007). Management of the acute partial-thickness burned hand; moist exposed burn ointment or silver sulphadiazine cream both combined with a polyethylene bag. Ann. Burns Fire Disasters 20(3):144.

Al-Meshaan M, Hamid MA, Quider T, Al-Sairafi A, Dham R (2008). Role of Mebo (Moist Exposed Burn Ointment) in the Treatment of Fournier'S Gangrene. Ann. burns Fire Disaster 21(1):20.

Al-Numairy A (2000). Clinical Use of MEBO in Wounds Management in UAE. Int. J. Cosmet. Surg. Aesthet. Dermatol. 2(1):27-33.
Crossref

Ang E, Lee ST, Gan CS, Chan YH, Cheung YB, Machin D (2003). Pain control in a randomized, controlled, clinical trial comparing moist exposed burn ointment and conventional methods in patients with partial-thickness burns. J. Burn Care Res. 24(5):289-296.
Crossref

Ang ES, Lee ST, Gan CS, See P, Chan YH, Ng LH, Machin D (2000). The role of alternative therapy in the management of partial thickness burns of the face-experience with the use of moist exposed burn ointment (MEBO) compared with silver sulphadiazine. Ann. Acad. Med. Singap. 29(1):7-10.

Atiyeh BS, Dham R, Kadry M, Abdallah AF, Al-Oteify M, Fathi O, Samir A (2002). Benefit–cost analysis of moist exposed burn ointment. Burns 28(7):659-663.
Crossref

Cao JH, Yang XJ, Gao YL, Liu JL, Wei FY, Zhang YH (2015). Clinic observation of Moist Exposed Burn Ointment combined with laser irradiation on diabetic foot. J. Chin. Rural Health 12:31-32.

Chen M, Zheng H, Yin LP, Xie CG (2010).Is Oral Administration of Chinese Herbal Medicine Effective and Safe as an Adjunctive Therapy for Managing Diabetic Foot Ulcers? A Systematic Review and Meta-Analysis. J. Altern. Complement. Med.16(8):889-898.
Crossref

Cui ST, Xu B, Ge K, TY Zhou, YG Zhang, H Peng (2008). Effect of MEBO on the Healing of diabetic Ulcer Wound at the lower Extremeties. J. Chin. J. Burns Wounds Surf Ulcers 20(3):217-219.

Deng XX, Li YR (2007).Clinicobservation and nursing of Moist Exposed Burn Ointment combined with frequency spectrum therapy apparatus for the treatment of diabetic foot. J. Tot. Nurs. 4:68-69.

Dhatariya K, Gooday C, Franke B, Pilling T, Flanagan A, Zeidan L (2016). An open, non-comparative, multicentre evaluation of performance and safety using an antimicrobial exudate transfer dressing on diabetic foot ulcers: a case series. J. Wound care 25(5):256-265.
Crossref

Du JJ, Zhang L, Zhang JH (2012) .Clinic observation of Vacuum sealing drainage combined with Moist Exposed Burn Ointment in treatment of diabetic foot of 16 cases. Guangxi. J. Tradit. Chin. Med. 35(1):21-22.

El-Hadidy MR, El-Hadidy AR, Bhaa A, Asker SA, Mazroa SA (2014). Role of epidermal stem cells in repair of partial-thickness burn injury after using Moist Exposed Burn Ointment (MEBO®) histological and immunohistochemical study. Tissue Cell 46(2):144-151.
Crossref

Elraiyah T, Prutsky G, Domecq JP, Tsapas A, Nabhan M, Frykberg RG, Firwana B, Hasan R, Prokop LJ, Murad MH (2016). A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers. J. Vascular Surg. 63(2):59S-68S.
Crossref

Ezzo J, Berman BM, Vickers AJ, Linde K (1998). Complementary medicine and the Cochrane Collaboration. Jama, 280(18):1628-1630
Crossref

Gong SH (2011). Clinic observation of Moist Exposed Burn Ointment in treatment of diabetic foot ulcer wound of 42 cases. J. Shandong. J. Tradit. Chin. Med. 30(9):620-621. Available at: 

View

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JA (2011). The cochrane collaboration's tool for assessing risk of bias in randomisedtrials. BMJ 343:d5928.
Crossref

Hindy AMGAD (2009). Comparative study between sodium carboxymethyl-cellulose silver, moist exposed burn ointment, and saline-soaked dressing for treatment of facial burns. Ann. Burns Fire Disasters 22(3):131.

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996). Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clin. Trials 17(1):1-12.
Crossref

Jewo PI, Fadeyibi IO, Babalola OS, Saalu LC, Benebo AS, Izegbu MC, Ashiru OA (2009). A comparative study of the wound healing properties of moist exposed burn ointment (MEBO) and silver sulphadiazine. Ann. Burns Fire Disasters 22(2):79.

Jiang LL (2012). Efficacy Observation of MEBO Wound Ointment Combined with Chinese Medicine Tongmai Decoration in the Treatment of Diabetic Foot Ulcer. Chin. J. Burns. Wounds. Surface. Ulcers. 24(3):217-224. Available at: 

View

Karri VV, Kuppusamy G, Talluri SV, Yamjala K, Mannemala SS, Malayandi R (2015). Current and emerging therapies in the management of diabetic foot ulcers. Current Med. Res. Opinion 32(3):519-542.
Crossref

Lavery LA, Ashry HR,Van HW, Pugh JA, Harkless LB(1996). Variation in the Incidence and Proportion of Diabetes-Related Amputations in Minorities. Diabetes care 19(1):48-52.
Crossref

Lee AL, Chen BC, Mou CH, Sun MF, Yen HR (2016). Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus: a nationwide, retrospective, Taiwanese-registry, cohort study. Medicine 95(3).
Crossref

Li JH, Huang X, Tang QL, Huang XS, Huang ZH (2016).Clinical Curative Effect Observation of MEBT/BEBO in the treatment of Diabetic Foot Ulcers.J. Chin J Burns Wounds Surf Ulcers. 28(1):22-24. Available at: 

View

Li JH, Wang L, Du JJ, Zhang L, Tang QL (2012). Moist Exposed Burn Ointment on the expressionof Bcl-2 and Bax apoptosis gene. J. Lishizhen Med and Mate Med Res. 23(7):1616-1617.Available at: 

View

Li S, Zhao J, Liu J, Xiang F, Lu D, Liu B, Xu J, Zhang H, Zhang Q, Li X, Yu R (2011). Prospective randomized controlled study of a Chinese herbal medicine compound Tangzu Yuyang Ointment for chronic diabetic foot ulcers: A preliminary report. J. Ethnopharmacol. 133(2):543-550.
Crossref

Li YJ, Zhao ZF, Ma QM, Xu JF, Li JB, Feng XY(2010). Clinical observation of treating ulcers or gangrene of diabetic foot with MEBO ointment combined with PTA therapy. J. Chin. J. Burns. Wounds. Surface Ulcers 22(6):466-467. Available at: 

View

Liang SE, Wu HQ, Liang RQ (2007). Observation cream for diabetic foot ulcer moist burn effect of MEBO on wounds of diabetic foot ulcer. J. Pract. Med. Technol. 14(7):849-850. Available at: 

View

Liu X, Feng CG (2005). Recent advances in TCM treatment of diabetic gangrene. Chinese J. Tradit. Chinese Med.25(1):70-7.

Liu XY (2016).The study on MEBO and epidermal growth factor treatment for 50 cases of diabetic foot. Contemporary Medicine Forum 14(12):95-96. Available at: 

View

Lou SP, Sun YL (2006). Application and nursing of MEBO in dressing change of diabetic foot ulcer. Available at: 

View

Maydick DR, Acee AM (2016). Comorbid Depression and Diabetic Foot Ulcers. Home healthcare Now 34(2):62-67.

Mazze RS, Sinnock P, Deeb L, Brimberry JL (1985). An epidemiological model for diabetes mellitus in the United States: Five major complications. Diabetes Res. Clin. Pract.1(3):185-191.
Crossref

Perez-Zabala E, Basterretxea A, Larrazabal A, Perez-del-Pecho K, Rubio-Azpeitia E, Andia I (2016). Biological approach for the management of non-healing diabetic foot ulcers. J. Tissue Viability 25(2):157-163.
Crossref

Qing Y, Wei P (2015). Comparison of the curative effect between MEBO and negative pressure drainage technique in treatment of diabetic foot: Therapeutic effect comparison between moist exposed burn ointment (MEBO) and vacuum sealing drainage (VSD) in diabetic foot patients. Chin. J. Burn Wound Surface Ulcer 27(4):263-264. Available at: 

View

Ren SQ (2016).The Clinical Observation in 36 Cases of MEBO for Treating Early Diabetic Foot. Diabetes New World19(9):27-28. Available at: 

View

Renliang H, Zhihe Y, Yingxiang L, Xiyu C, Fengchun L, Liu Y (2010). Clinical study of moist exposed burn ointment in treating for chronic diabetic skin ulcer [J]. Modern J. Integrated Tradit. Chinese Western Med. 10:003.

Sakr MF, Hamed HM, Yong-chong C, Gui-ru LI, Yong Z (2012). The multi-cen-ters comparative study of moist exposed burn ointment (MEBO) in healing of chronic diabetic foot ulcers. Chinese J. Burns Wounds Surf. Ulcers 24(2):102-118.

Qi JZ (2013).Curative effect analysis of Moist Exposed Burn Ointment combined with insulin and 654-2 for the treatment of early diabetic foot. Seek Med. Ask Med. 11(7):52-54. Available at: 

View

See GJ, Chan YH, Lee-Hua Ng BN, Machin D (2001). Evaluating the role of alternative therapy in burn wound management: randomized trial comparing moist exposed burn ointment with conventional methods in the management of patients with second-degree burns. Medscape/General Med. 3(12):3-18.

Serra R, Grande R, Scarcello E, Buffone G, de Franciscis S (2015). Angiosome‐targeted revascularisation in diabetic foot ulcers. Int. Wound J. 12(5):555-558.
Crossref

Smith-Strøm H, Iversen MM, Graue M, Skeie S, Kirkevold MM (2016). An integrated wound-care pathway, supported by telemedicine, and competent wound management-Essential in follow-up care of adults with diabetic foot ulcers. Int. J. Med. Informatics 94:59-66.
Crossref

Søndergaard LN,Christensen AB, Vinding AL, Kjær IL, Larsen PE(2015).Levated costs and high one-year mortality in patients with diabetic foot ulcers after surgery. Dan. Med. J. 62(4):A5050.

Sun X (2012). Therapeutic Effect of MEBO MEBO plus Insulin on Skin Wound in Diabetics. Today Nurse 3:33-35. Available at: 

View

Tang QL, Han SS, Feng J, Di JQ, Qin WX, Fu J, Jiang QY (2014). Moist exposed burn ointment promotes cutaneous excisional wound healing in rats involving VEGF and bFGF. Mol. Med. Rep. 9(4):1277-1282.
Crossref

Tsati E, Panayotou P, Ioannovich J (2004). Moist exposed burn therapy: evaluation of the wound healing process. An experimental model to assess the efficacy of local agents on wound repair in partial-and full-thickness wounds. Eur. J. Plastic Surg. 27(4):171-177.
Crossref

van Tulder M, Furlan A, Bombardier C, Bouter L(2003). Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine (Phila Pa 1976). 28(12):1290-1299. Available at: 

View
Crossref

Vincy LWS (2004). Comparison of Moist Exposed Burn Ointment (MEBO) with Silver Sulfadiazine (Ag-S) for the Treatment of Deep Burn Injury. pp. 1-75.

Wagner FW (1981). The dysvascular foot: a system for diagnosis and treatment. Foot ankle 2(2):64-122.
Crossref

Wang CJ, Cheng JH, Kuo YR, Schaden W, Mittermayr R (2015). Extracorporeal shockwave therapy in diabetic foot ulcers. Int. J. Surg. 24:207-209.
Crossref

Wang S, Yan T, Wang XQ (2011). Observation on the effect of MEBO combined with rb-bFGF in patients on treatment of diabetic foot. J.

Wang X (2013). MEBO Combined with epidermal growth factor for

Wang ZD (2015). Clinical efficacy and mechanism of MEBO combined with hyperbaric oxygen on diabetic foot ulcer. China Foreign Med. Treat.17:113-115. Available at: 

View

Watkins PJ (2003).ABC of diabetes: The diabetic foot. BMJ: Brit. Med. J. 326(7396):977
Crossref

Wolcott R (2015).Economic aspects of biofilm-based wound care in diabetic foot ulcers. J. Wound Care 24(5):189-94.
Crossref

Scott G (2013).The diabetic foot examination: A positive step in the prevention of diabetic foot ulcers and amputation. Osteopathic Family Phys. 5(2):73-78.
Crossref

Wu YJ, Jing DM, Xu H (2012). Thirty Patients with Diabetic Foot Treated by Micro - balloon Expansion Combined with MEBO. Chin. J. Tradit. Med. Sci. Technol. 19(3):278-279. Available at: 

View

XU Rongxiang (2015). MEBO-DFU regenerative therapy for the standardization of diabetic foot [J]. Chinese J. Burns Wounds Surface Dis. 27(1):1-16.

Yang HZ, Ma SQ, Lv JQ, Li BB (2011). Effect of MEBO combined with electromagnetic wave on skin infection in diabetic patients. J. Nurse 18 (3B):60-61. Available at: 

View

Yang XH, Liu XY (2010). Effect of MEBO in treating 52 cases of diabetic foot. Sichuan Med. J. 31(11):1649-1651. Available at: 

View

Yao M, Hasturk H, Kantarci A, Gu G, Garcia‐Lavin S, Fabbi M, Park N, Hayashi H, Attala K, French MA, Driver VR (2014). A pilot study evaluating non‐contact low‐frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers. Int. Wound J. 11(6):586-593.
Crossref

Yotsu RR, Pham NM, Oe M, Nagase T, Sanada H, Hara H, Fukuda S, Fujitani J, Yamamoto-Honda R, Kajio H, Noda M (2014). Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type. J. Diabetes Complications 28(4):528-535.
Crossref

Zhang CX, Li JH, Huang XS, Huang GL (2015). Efficacy of MEBO dressing in treating diabetic foot ulcer with TCM syndrome differentiation. Guangxi Med. J. 37(12):1712-1715. Available at: 

View

Zhang HQ, Yip TP, Hui I, Lai V, Wong A (2005). Efficacy of moist exposed burn ointment on burns. J. Burn Care Res. 26(3):247-251.

Zhang JM, Zhang HL (2005). Efficacy observation of MEBO applying infrared irradiation on diabetic foot. modern Clin. Nurse 4(4):13-14. Available at: 

View